Hiroyuki Shimizu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hiroyuki Shimizu has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Masatomo Mori
5 shared publicationsShuichi Okada
4 shared publicationsM. Mori
Department of Medicine and Molecular Science (H.S., S.O.-I., K.H., K.I., T.S., S.O., M.Y., M.M.), Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan
2 shared publicationsMasaaki Mori
Department of Lifetime Clinical Immunology, Graduate School, Tokyo Medical and Dental University
2 shared publicationsS. Okada
Department of Medicine and Molecular Science (H.S., S.O.-I., K.H., K.I., T.S., S.O., M.Y., M.M.), Gunma University Graduate School of Medicine, Maebashi 371-8511, Japan
2 shared publicationsShinsuke Oh-I
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371, Japan
2 shared publications
Latest Publications
- 1 January 2017
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 243 (3) , 205-210
Usefulness of the Combination of Tuberculin Skin Test and Interferon-Gamma Release Assay in Diagnosing Children with Tuberculosis
Japan is still designated as a medium incidence country, worldwide. Although the definitive diagnosis of tuberculosis is made by detecting pathogen from tissue specimens, collecting those from children is physically difficult. Therefore, we must frequently depend on the results of tuberculin skin test (TST) or interferon-gamma release assay (IGRA). However, the value of IGRA in diagnosing tuberculosis in infants remains unclear. We implemented TST and IGRA concurrently and examined the significance of combining these two tests by analyzing cases where conflicting results were evident from other tests. Subjects included 52 children (24 boys, 28 girls) age 15 years or younger (4.0 ± 3.4 years) who visited our hospital for close examination after medical checkup for tuberculosis contact tracing. The children underwent TST, T-SPOT®.TB, chest plain radiography, and chest computed tomography with a view to tuberculosis diagnosis during a 26-months period from January 2013 to March 2015. T-SPOT results were positive in 9/52 cases (17.3%), and TST results were positive in 12/52 cases (23.1%). Conflicting results were observed in 7/52 cases (13.5%), and all cases were treated as latent tuberculosis infection or incident cases of tuberculosis. The value of T-SPOT in tuberculosis diagnosis in children is still being established. However, there are a number of cases where conflicting results for T-SPOT and TST are indicated. Thus, it is currently desirable to use T-SPOT and TST concomitantly for children at an early age, especially for children below the age of 5 years, as a diagnostic measure in complementing other techniques.
- 1 January 2017
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 243 (3) , 205-210
Usefulness of the Combination of Tuberculin Skin Test and Interferon-Gamma Release Assay in Diagnosing Children with Tuberculosis
Japan is still designated as a medium incidence country, worldwide. Although the definitive diagnosis of tuberculosis is made by detecting pathogen from tissue specimens, collecting those from children is physically difficult. Therefore, we must frequently depend on the results of tuberculin skin test (TST) or interferon-gamma release assay (IGRA). However, the value of IGRA in diagnosing tuberculosis in infants remains unclear. We implemented TST and IGRA concurrently and examined the significance of combining these two tests by analyzing cases where conflicting results were evident from other tests. Subjects included 52 children (24 boys, 28 girls) age 15 years or younger (4.0 ± 3.4 years) who visited our hospital for close examination after medical checkup for tuberculosis contact tracing. The children underwent TST, T-SPOT®.TB, chest plain radiography, and chest computed tomography with a view to tuberculosis diagnosis during a 26-months period from January 2013 to March 2015. T-SPOT results were positive in 9/52 cases (17.3%), and TST results were positive in 12/52 cases (23.1%). Conflicting results were observed in 7/52 cases (13.5%), and all cases were treated as latent tuberculosis infection or incident cases of tuberculosis. The value of T-SPOT in tuberculosis diagnosis in children is still being established. However, there are a number of cases where conflicting results for T-SPOT and TST are indicated. Thus, it is currently desirable to use T-SPOT and TST concomitantly for children at an early age, especially for children below the age of 5 years, as a diagnostic measure in complementing other techniques.
- 1 January 2015
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 54 (17) , 2155-2159
Clostridium difficile Infection Is More Severe When Toxin Is Detected in the Stool than When Detected Only by a Toxigenic Culture
The cases of CDI in which the toxins were detected by the initial screening test were more severe than those where the toxins were not detected at the initial screening but were identified by the toxigenic culture. In addition, the most significant factors affecting the severity score were an older age and a lower serum albumin level.
- 1 January 2015
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 54 (17) , 2155-2159
Clostridium difficile Infection Is More Severe When Toxin Is Detected in the Stool than When Detected Only by a Toxigenic Culture
The cases of CDI in which the toxins were detected by the initial screening test were more severe than those where the toxins were not detected at the initial screening but were identified by the toxigenic culture. In addition, the most significant factors affecting the severity score were an older age and a lower serum albumin level.
- 1 January 2011
- p. 109-14
[Inhibitory factors of feeding behavior and its physiological roles].
- 22 September 2009
- Published by Springer Nature
- p. 143-158
Leptin Signaling Pathway
- Open Access
- 1 February 2009
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (2) , 662-671
Peripheral Administration of Nesfatin-1 Reduces Food Intake in Mice: The Leptin-Independent Mechanism
Nesfatin-1 is a novel satiety molecule in the hypothalamus and is also present in peripheral tissues. Here we sought to identify the active segment of nesfatin-1 and to determine the mechanisms of its action after peripheral administration in mice. Intraperitoneal injection of nesfatin-1 suppressed food intake in a dose-dependent manner. Nesfatin-1 has three distinct segments; we tested the effect of each segment on food intake. Injection of the midsegment decreased food intake under leptin-resistant conditions such as db/db mice and mice fed a high-fat diet. After injection of the midsegment, expression of c-Fos was significantly activated in the brainstem nucleus tractus solitarius (NTS) but not in the hypothalamic arcuate nucleus; the nicotinic cholinergic pathway to the NTS contributed to midsegment-induced anorexia. Midsegment injection significantly increased expression of proopiomelanocortin and cocaine- and amphetamine-regulated transcript genes in the NTS but not in the arcuate nucleus. Investigation of mutant midsegments demonstrated that a region with amino acid sequence similarity to the active site of agouti-related peptide was indispensable for anorexigenic induction. Our findings indicate that the midsegment of nesfatin-1 causes anorexia, possibly by activating POMC and CART neurons in the NTS via a leptin-independent mechanism after peripheral stimulation. Peripherally administered nesfatin-1 and its mid-segment suppress food intake in mice. The nicotinic cholinergic pathway to the nucleus tractus solitarius contributes to the anorexigenic action of the mid-segment.
- 1 February 2009
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (2) , 662-671
Open AccessPeripheral Administration of Nesfatin-1 Reduces Food Intake in Mice: The Leptin-Independent Mechanism
Nesfatin-1 is a novel satiety molecule in the hypothalamus and is also present in peripheral tissues. Here we sought to identify the active segment of nesfatin-1 and to determine the mechanisms of its action after peripheral administration in mice. Intraperitoneal injection of nesfatin-1 suppressed food intake in a dose-dependent manner. Nesfatin-1 has three distinct segments; we tested the effect of each segment on food intake. Injection of the midsegment decreased food intake under leptin-resistant conditions such as db/db mice and mice fed a high-fat diet. After injection of the midsegment, expression of c-Fos was significantly activated in the brainstem nucleus tractus solitarius (NTS) but not in the hypothalamic arcuate nucleus; the nicotinic cholinergic pathway to the NTS contributed to midsegment-induced anorexia. Midsegment injection significantly increased expression of proopiomelanocortin and cocaine- and amphetamine-regulated transcript genes in the NTS but not in the arcuate nucleus. Investigation of mutant midsegments demonstrated that a region with amino acid sequence similarity to the active site of agouti-related peptide was indispensable for anorexigenic induction. Our findings indicate that the midsegment of nesfatin-1 causes anorexia, possibly by activating POMC and CART neurons in the NTS via a leptin-independent mechanism after peripheral stimulation. Peripherally administered nesfatin-1 and its mid-segment suppress food intake in mice. The nicotinic cholinergic pathway to the nucleus tractus solitarius contributes to the anorexigenic action of the mid-segment.
- Open Access
- 1 January 2009
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 56 (4) , 537-543
Nesfatin-1: An Overview and Future Clinical Application
Nesfatin/nucleobindin 2 (NUCB2) is expressed in the appetite-control hypothalamic nuclei and brainstem nuclei. Nesfatin/NUCB2 expression in the paraventricular nucleus of the hypothalamus was modulated by starvation and refeeding. Intracerebroventricular administration of nesfatin-1 dose-dependently inhibited food intake for 6 hours in male Wistar and leptin resistant, Zucker fatty rats. Intraperitoneal administration of nesfatin-1 and its mid-segment (M30) dosedependentlyinhibited food intake for 3 hours in male ICR mice. Intraperitoneal administration of M30 also decreased foodintake in leptin-resistant, genetically obese (ob/ob), diabetic (db/db) mice and mice fed a 45% high fat diet for 28 days. Intraperitoneal administration of M30 increased proopiomelanocortin and cocaine- and amphetamine- related peptide mRNA expression in the nucleus of the solitary tract of mice. In addition, intranasal administration of nesfatin-1 significantly inhibited food intake for 6 hours in male Wistar rats. We summarize recent observations about nesfatin-1, and attempt to present future direction of nesfatin-1 research for developing a new anti-obesity treatment.
- 1 January 2009
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 56 (4) , 537-543
Open AccessNesfatin-1: An Overview and Future Clinical Application
Nesfatin/nucleobindin 2 (NUCB2) is expressed in the appetite-control hypothalamic nuclei and brainstem nuclei. Nesfatin/NUCB2 expression in the paraventricular nucleus of the hypothalamus was modulated by starvation and refeeding. Intracerebroventricular administration of nesfatin-1 dose-dependently inhibited food intake for 6 hours in male Wistar and leptin resistant, Zucker fatty rats. Intraperitoneal administration of nesfatin-1 and its mid-segment (M30) dosedependentlyinhibited food intake for 3 hours in male ICR mice. Intraperitoneal administration of M30 also decreased foodintake in leptin-resistant, genetically obese (ob/ob), diabetic (db/db) mice and mice fed a 45% high fat diet for 28 days. Intraperitoneal administration of M30 increased proopiomelanocortin and cocaine- and amphetamine- related peptide mRNA expression in the nucleus of the solitary tract of mice. In addition, intranasal administration of nesfatin-1 significantly inhibited food intake for 6 hours in male Wistar rats. We summarize recent observations about nesfatin-1, and attempt to present future direction of nesfatin-1 research for developing a new anti-obesity treatment.
- 31 May 2007
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 1 (2) , 119-123
Incidence of β3-adrenergic receptor polymorphism and prediction of successful weight reduction with mazindol therapy in severely obese Japanese subjects
- 31 May 2007
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 1 (2) , 119-123
Incidence of β3-adrenergic receptor polymorphism and prediction of successful weight reduction with mazindol therapy in severely obese Japanese subjects
- 16 February 2006
- Published by Wiley in Diabetic Medicine
- Vol. 23 (3) , 253-257
Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF‐α levels in Type 2 diabetic patients: a randomized study
Background Adipocytokines are involved in the development of insulin resistance and endothelial dysfunction in diabetic patients. However, the relationship between these factors remains unclear. We observed a chronological change in circulating adipocytokines and blood pressure levels with administration of oral hypoglycaemic agents in Type 2 diabetic (T2DM) subjects.Methods Thirty poorly controlled T2DM subjects (aged 60.1 ± 1.5 years, 11 males and 19 females) were randomized into two groups: voglibose (initial dose 0.6 mg/day, increased to 0.9 mg/day) and pioglitazone (initial dose 15 mg/day, increased to 30 mg/day).Results Both treatment groups showed a similar improvement in glycaemic control. In pioglitazone‐treated patients, circulating adiponectin levels were significantly increased from 4 weeks after the start of treatment, and until the end of the study at 12 weeks. Plasma tumour necrosis factor‐α (TNF‐α) levels were significantly decreased only at 12 weeks. In contrast, no significant changes in plasma adiponectin or TNF‐α levels were observed in voglibose‐treated patients. Plasma PAI‐1 and leptin levels were not significantly changed at 12 weeks in either treatment group. Pioglitazone significantly decreased systolic and diastolic blood pressure levels at 12 weeks, but voglibose had no effect.Conclusion In summary, pioglitazone caused an immediate increase in circulating adiponectin levels, followed by a reduction of TNF‐α. The observed increase in circulating adiponectin could be related to decreases in both systolic and diastolic blood pressure.
- 16 February 2006
- Published by Wiley in Diabetic Medicine
- Vol. 23 (3) , 253-257
Pioglitazone increases circulating adiponectin levels and subsequently reduces TNF‐α levels in Type 2 diabetic patients: a randomized study
Background Adipocytokines are involved in the development of insulin resistance and endothelial dysfunction in diabetic patients. However, the relationship between these factors remains unclear. We observed a chronological change in circulating adipocytokines and blood pressure levels with administration of oral hypoglycaemic agents in Type 2 diabetic (T2DM) subjects.Methods Thirty poorly controlled T2DM subjects (aged 60.1 ± 1.5 years, 11 males and 19 females) were randomized into two groups: voglibose (initial dose 0.6 mg/day, increased to 0.9 mg/day) and pioglitazone (initial dose 15 mg/day, increased to 30 mg/day).Results Both treatment groups showed a similar improvement in glycaemic control. In pioglitazone‐treated patients, circulating adiponectin levels were significantly increased from 4 weeks after the start of treatment, and until the end of the study at 12 weeks. Plasma tumour necrosis factor‐α (TNF‐α) levels were significantly decreased only at 12 weeks. In contrast, no significant changes in plasma adiponectin or TNF‐α levels were observed in voglibose‐treated patients. Plasma PAI‐1 and leptin levels were not significantly changed at 12 weeks in either treatment group. Pioglitazone significantly decreased systolic and diastolic blood pressure levels at 12 weeks, but voglibose had no effect.Conclusion In summary, pioglitazone caused an immediate increase in circulating adiponectin levels, followed by a reduction of TNF‐α. The observed increase in circulating adiponectin could be related to decreases in both systolic and diastolic blood pressure.
- 1 May 2005
- Published by Elsevier in Cell Metabolism
- Vol. 1 (5) , 331-341
Molecular mechanisms associated with leptin resistance: n-3 polyunsaturated fatty acids induce alterations in the tight junction of the brain
- 1 May 2005
- Published by Elsevier in Cell Metabolism
- Vol. 1 (5) , 331-341
Molecular mechanisms associated with leptin resistance: n-3 polyunsaturated fatty acids induce alterations in the tight junction of the brain